<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">DIETHYLPROPION HYDROCHLORIDE <img border="0" src="../images/pr.gif"/></span><br/>(dye-eth-il-proe'pee-on)<br/><span class="topboxtradename">Nobesine <img border="0" src="../images/maple.gif"/>, </span><span class="topboxtradename">Propion, </span><span class="topboxtradename">Ten-Tab, </span><span class="topboxtradename">Tenuate, </span><span class="topboxtradename">Tenuate Dospan, </span><span class="topboxtradename">Tepanil<br/></span><b>Classifications:</b> <span class="classification">gastrointestinal agent</span>; <span class="classification">anorexiant</span><br/><b>Pregnancy Category: </b>B<br/><b>Controlled Substance: </b>Schedule IV<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>25 mg tablets; 75 mg sustained release tablets</p>
<h1><a name="action">Actions</a></h1>
<p>Sympathomimetic amine and amphetamine congener. Has lower incidence of amphetamine-type adverse effects but reportedly is
         less effective as an appetite suppressant. Anorexigenic action probably secondary to direct (CNS) stimulation of appetite
         control center in hypothalamus and limbic regions. Also produces mild psychic stimulation and vasopressor effects.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Suppresses appetite as a result of drug action on CNS appetite control center.</p>
<h1><a name="uses">Uses</a></h1>
<p>Used solely in management of exogenous obesity as short-term (a few weeks) adjunct in a regimen of weight reduction based
         on caloric restriction.
      </p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Known hypersensitivity or idiosyncrasy to sympathomimetic amines; severe hypertension, advanced arteriosclerosis; hyperthyroidism;
         glaucoma; agitated states, history of drug abuse. Safe use during pregnancy (category B) or in children 
      </p><h1><a name="precaution">Cautious Use</a></h1>
<p>Hypertension, arrhythmias, symptomatic cardiovascular disease; epilepsy; diabetes mellitus; lactation.</p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Obesity</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 25 mg t.i.d. 3060 min a.c. or 75 mg sustained release q.d. midmorning<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li>Give on an empty stomach, ½1 h before meals.</li>
<li> 					Note: Additional dose sometimes prescribed in midevening to control nighttime hunger. Rarely causes insomnia except in high doses. 				</li>
<li>Titrate dosage carefully in patients with diabetes.</li>
<li>Store between 15°30° C (59°86° F) in well-closed container unless otherwise specified.</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">Body as a Whole:</span> Hypersensitivity (urticaria, rash, erythema); muscle pain, dyspnea, hair loss, blurred vision, severe dermatoses (chronic
      intoxication), increased sweating. <span class="typehead">CNS:</span> Mild euphoria, restlessness, <span class="speceff-common">nervousness,</span> dizziness, headache, irritability, hyperactivity, insomnia, drowsiness, mood changes, lethargy, increase in convulsive episodes
      in patients with epilepsy. <span class="typehead">CV:</span> Palpitation, tachycardia, precordial pain, rise in BP. <span class="typehead">GI:</span> Nausea, vomiting, diarrhea, constipation, dry mouth, unpleasant taste. <span class="typehead">Urogenital:</span> Impotence, changes in libido, gynecomastia, menstrual irregularities; polyuria, dysuria. 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span> <b>Acetazolamide,</b> <b>sodium bicarbonate</b> decrease diethylpropion elimination; <b>ammonium chloride,</b> <b>ascorbic acid</b> increase diethylpropion elimination; a <span class="classification">barbiturate</span> and diethylpropion taken together may antagonize the effects of both drugs; <b>furazolidone</b> may increase blood pressure effects of <span class="classification">amphetamines</span>, and interaction may persist for several weeks after discontinuation of <b>furazolidone;</b> <b>guanethidine,</b> <b>guanadryl</b> antagonize antihypertensive effects; <span class="classification">mao inhibitors</span>, <b>selegiline</b> can cause hypertensive crisis (fatalities reported)<span class="classification">amphetamines</span> should not be administered at the same time as or within 14 days of these drugs; <span class="classification">phenothiazines</span> may inhibit mood elevating effects of <span class="classification">amphetamines</span>; <span class="classification">tricyclic antidepressants</span> enhance <span class="classification">amphetamines'</span> effects by increasing <b>norepinephrine</b> release; <span class="classification">beta agonists</span> increase cardiovascular adverse effects. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Readily absorbed from GI tract. <span class="typehead">Duration:</span> 4 h, regular tablets; 1014 h, sustained release. <span class="typehead">Elimination:</span> Excreted in urine. <span class="typehead">Half-Life:</span> 46 h. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Observe patients with epilepsy closely for reduction in seizure control.</li>
<li>Anorexigenic effect seldom lasts more than a few weeks. Discontinue if tolerance develops.</li>
<li> 								Note: Varying degrees of psychologic and rarely physical dependence can occur. 							</li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Swallow sustained release tablets whole; do <small>NOT</small> chew.
         </li>
<li>Do not drive or engage in other potentially hazardous activities until reaction to drug is known.</li>
<li>Do not breast feed while taking this drug without consulting physician.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>